Washington Post Examines Haiti's Efforts To Fight Lymphatic Filariasis

The Washington Post reports on Haiti’s efforts to fight lymphatic filariasis, a parasitic mosquito-borne disease that can cause elephantiasis and is present in 80 percent of the country. Haiti’s health ministry is working to reach the country’s 10 million people with “mass drug administration” to prevent the disease, according to the newspaper, which notes IMA World Health, RTI International, and the University of Notre Dame are providing advice and a foundation associated with Abbott Laboratories is supplying salaries. “After years of mass drug administrations, nine countries — Burundi, Cape Verde, Costa Rica, Mauritius, Rwanda, Seychelles, the Solomon Islands, Suriname, and Trinidad and Tobago — were declared free of lymphatic filariasis in 2011 by the World Health Organization. Haiti hopes to join them,” the Washington Post writes. In a separate article, the newspaper examines how beliefs in voodoo sometimes hamper care for people with elephantiasis, and it provides a fact sheet on the infection and other neglected tropical diseases, as well as a photographic slideshow (Brown, 9/30).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.